• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of Novel CNS Drug Delivery System by Regulating the BBB Efflux Transport System

Research Project

Project/Area Number 09672332
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionUniversity of Shizuoka

Principal Investigator

DEGUCHI Yoshiharu  University of Shizuoka, School of Pharmaceutical Sciences, Research Associate, 薬学部, 助手 (40254255)

Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 1998: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1997: ¥1,800,000 (Direct Cost: ¥1,800,000)
Keywordsanion transport system / BBB efflux transport / Alzheimer's disease / ketoprofen / 6-mercaptopurine / improvement of CNS delivery / probenecid / prodrug / 血液脳関門 / 排出輸送 / モノカルボン酸輸送系 / 脳移行性改善 / ペプチド性薬物 / アセチルコリンエステラーゼ阻害薬 / 脳送達法 / 脳内代謝 / グリセロール
Research Abstract

There are increasing evidences that the drug efflux pump like P-glycoprotein in the blood- brain barrier (BBB) is actively extruded many drugs from brain to blood circulation, resulting in the limited distribution to the brain. The goal of this research was to find drugs that is recognized by the efflux transport system in the BBB, and to develop the novel drug delivery system in which the BBB efflux system is being regulated. 1) Patients with acute lymphoblastic leukemia who continuously receive 6-mercaptopurine (6-MP) are often brought about the CNS relapse. This may be caused by the restricted distribution of 6-MP in the brain. Therefore, the BBB transport of 6-MP was examined. As a result, it was found that the restricted 6-MP brain distribution may be ascribe to the active extrusion from the brain, possibly via the organic anion transport system and the monocarboxylic acid transport system. This study also suggests that the coadministration of a transport inhibitor like probenecid may improve this restricted 6-MP distribution in the brain. 2) Recently, it has been reported that nonsteroidal antiinflammatory drugs (NSAIDs) were effective to Alzheimer's disease. However, the distribution of NSAIDs into the brain is very limited. Therefore, in this study, it was examined whether a newly synthesized glyceride prodrug of ketoprofen (KT) improve the brain delivery of KT.DAKG could improve the brain uptake of KT from blood side to brain. In addition, the coadministration of probenecid with DAKG significantly improve the brain delivery of KT by inhibiting the efflux transport of KT which was metabolized from DAKG in the brain.
The findings obtained here will provide significant information for CNS drug discovery and CNS drug therapy.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Hayashi, H., Deguchi, Y.et al.: "An Attempt to Develop New CNS Pharmaceuticals against Alzheimer's Disease : Improvement of Brain Delivery of NSAIDs by〜." Progress in Drug Deliv.System.6. 53-61 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Deguchi, Y.et al.: "Brain Distribution of 6-Mercaptopurine Regulated by the Efflux Transport System in the Blood-Brain Barrier." J.Pharmacol.Exp.Ther.(in press). (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hayashi, H., Deguchi, Y.et al.: "An Attempt to Develop New CNS Pharmaceuticals against Alzheimer's Disease : Improvement of Brain Delivery of NSAIDs by -." Progress in Drug Deliv.System. 6. 53-61 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Deguchi, Y.et al.: "Brain Distribution of 6-Mercaptopurine Regulated by the Efflux Transport System in the Blood-Brain Barrier" J.Pharmacol.Exp.Ther.(in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hayashi,H., Deguchi,Y.et al.: "An Attempt to Develop New CNS Pharamaceuticals against Alzheimer's Disease:Improvement of Brain Delivery of NSAIDs by〜." Progress in Drug Deliv.System.6. 53-61 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi